Opioids are killing more people than ever, and Kansas lags other states on these steps to help

by Celia Llopis-Jepsen, KCUR and Kansas News Service

Evidence is mounting that good Samaritan laws save lives. Kansas is one of just a few states without a law to encourage people to call 911 if a friend is overdosing.

In September 2020, Seth Dewey got a phone call at home from someone using drugs.

“They said, ‘Seth, we need Narcan over here right now,’” Dewey said.

The call for Narcan suggested a life-and-death emergency requiring medicine that can reverse an opioid overdose.

Dewey, whose work for the Reno County Health Department in Hutchinson focuses on combating drug addiction and overdoses, promised to rush over with doses of what’s also known as naloxone to the site where two people panicked as they watched life slipping away from a third.

He urged them to call 911, too, but they feared getting arrested.

“So I said, ‘Well, listen, then I’m going to call 911,’” he said. “When I got there, I ended up having to use three doses of naloxone on this individual. … It brought back very slow, labored breathing.”

By the time law enforcement officers reached the scene — without any naloxone on hand — Dewey had stabilized the man. Medical responders arrived later.

For Dewey, that day illustrates the need for policy changes to help more people survive a national surge in opioid overdoses.

Kansas is one of just a few states without a good Samaritan law that encourages people to call 911 when witnessing an overdose, by shielding them from prosecution.

Additionally, Kansans can’t count on law enforcement officers — who may beat ambulances to the scene of an ongoing overdose when every minute counts — to carry naloxone.

Across the country, fatal overdoses rocketed in 2020 to more than 90,000. That record number was driven largely by dealers selling drugs laced with potent synthetic opioids such as fentanyl.

Tallies aren’t complete yet for 2021, but provisional counts for the first half of the year suggest people died at even greater rates. And Kansas is among a handful of states showing the steepest increases.

Studies show most people recover from drug use disorders, but the process often takes years and involves multiple relapses. The widespread practice of mixing fentanyl and carfentanil into so many drugs today means many people never get that far.

“We’re losing too many people due to this old idea that people have to hit rock bottom” before becoming sober, Dewey said. “People aren’t getting a chance to hit rock bottom, because they’re dying.”

Someone dies of overdose almost every month in Reno County — often more than one person.

Yet Dewey sees signs of change. The Reno County Sheriff’s Office and Hutchinson Police Department now train their officers on administering naloxone, and make sure they have it available.

A state good Samaritan law could also help, research suggests. The U.S. Government Accountability Office published a report last year documenting evidence that the rate of fatal opioid overdoses improves when states pass such laws.

Deadly synthetic opioids

The vast bulk of synthetic opioids such as fentanyl and carfentanil are smuggled from abroad, and increasingly blended with other substances.

That means people sometimes don’t know that the methamphetamine, oxycodone, cocaine or other substances they buy illegally contain synthetic opioids to make them more potent.

Overdosing is easy. Even minuscule amounts of these substances can kill. Fentanyl is up to 50 times more potent than heroin.

This month, a federal commission released its report on synthetic opioids, calling the epidemic of addiction “one of our most-pressing national security, law enforcement, and public health challenges.”

Though most people addicted to the substances get them illegally, the report traces the rise in demand for and trafficking of synthetic opioids directly to wide-scale addiction to OxyContin prescription opiate painkillers starting in the 1990s.

“The overdose crisis in the United States claims more lives each year than firearms, suicide, homicide, or motor vehicle crashes,” the report said. “We must do more as a nation and a government.”

Better access to medical care for opioid addiction won’t stop the drug trafficking, it said, but offers one route to saving lives, as the “gold standard” for treating opioid use disorders.

Buprenorphine and other treatments

Yet experts at the health care research group Commonwealth Fund say only a small sliver of people with opioid addiction receive such medical care.

The treatment usually involves prescribing one of three medications — buprenorphine, methadone or naltrexone — to ease cravings and even block the brain’s ability to experience euphoria from drugs like heroin and oxycodone.

Sometimes people who want this help struggle to find a health care provider and treatment program that they can afford. Sometimes they face insurance hurdles.

Meanwhile, access to drug treatment behind bars remains spotty at best, even though most incarcerated people have substance use disorders.

Despite some successful lawsuits, as well as federal legislation, pushing for widespread access to this treatment in correctional facilities, most people with addiction in prison or jail still don’t receive it.

In Kansas, a few jails have begun allowing medical care with buprenorphine, methadone or naltrexone. Since Crawford County Jail rolled out its program in August 2020, more than 200 people have signed up for care, and most continued their treatment after leaving jail.

A spokeswoman for the state prison system says it allows such treatment, too, though the Marshall Project — an investigative journalism newsroom focused on criminal justice — considers the access to care in Kansas prisons to be limited.

Fentanyl test strips and naloxone supplies

The federal commission urges Congress to help local governments across the country afford naloxone so that they can equip all first responders with it.

And it calls for fentanyl test strip distribution programs and the development of best practices to help guide that work.

The strips let people test drugs they buy on the street to see if they’re laced with fentanyl, so they can protect themselves against unknowingly consuming it.

Kansas overdose prevention programs can’t distribute the test strips because they’re illegal under state law.

Last year, the Kansas House passed a bill to change that. The bill is now stalled in a Senate committee, which began to hold a hearing on the topic and then postponed the matter.

If the test strips become legal in Kansas, community groups that help people struggling with addiction will be able to use federal grants to buy and distribute supplies.

Ngoc Vuong sees the potential to save lives. He coordinates anti-addiction efforts for the Safe Streets program in Wichita. He says part of helping people seek recovery is keeping them safe in the meantime.

That could mean distributing or explaining fentanyl test strips at outreach events geared toward people living on the street or who use illegal drugs or who are trying to stop using them.

“Letting them know about fentanyl test strips, how to use them,” Vuong said. “Then also add the caveat here that, ‘Whenever you’re ready to seek treatment, we’re here to help.’”

Dewey, at the Reno County Health Department, has a similar perspective. Building relationships is key, he said. And that includes talking to people in crisis about how to use naloxone and fentanyl test strips, and making sure they have access.

“Then they’re at least honest with us,” he said. “We want people to be honest with us. ‘Hey, man, I’m struggling with this.’”

Dewey speaks from experience. He used illegal drugs in the past, and ended up in the county jail. Ultimately he achieved long-term recovery.

“When we open up that relationship of trust” with people who use drugs, he said, “that’s when we start seeing a full cycle of (approaches) that could be used to help people when they’re ready.”

Celia Llopis-Jepsen reports on consumer health for the Kansas News Service. You can follow her on Twitter @celia_LJ or email her at celia (at) kcur (dot) org.
The Kansas News Service is a collaboration of KCUR, Kansas Public Radio, KMUW and High Plains Public Radio focused on health, the social determinants of health and their connection to public policy.
Kansas News Service stories and photos may be republished by news media at no cost with proper attribution and a link to ksnewsservice.org.
See more at https://www.kcur.org/news/2022-03-01/opioids-are-killing-more-people-than-ever-and-kansas-lags-other-states-on-these-steps-to-help
.

UG Health Department provides more details about Similac baby formula recall

Similac, Similac Alimentum and EleCare have been recalled for possible salmonella contamination.

The Unified Government Public Health Department is providing additional details about the ongoing recall of several Similac powdered baby formula products, and urged parents and caregivers to immediately check any products they have before giving them to infants.

The products being recalled are all manufactured by Abbott. This recall is specific to three powdered baby formulas: Similac, Alimentum and EleCare.

According to the manufacturer’s recall announcement, these products are being recalled after the company received four consumer complaints related to Cronobacter sakazakii or Salmonella Newport in infants who had consumed powdered infant formula manufactured in a facility located in Sturgis, Michigan. The recall does not include any metabolic deficiency nutrition formulas.

What parents and caregivers should do

According to the manufacturer’s recall notice, the products under recall have a multidigit number on the bottom of the container, starting with the first two digits 22 through 37, containing K8, SH or Z2 and with an expiration date of April 1, 2022, or after.

To find out if the product you have is included in this recall, visit the Abbott Product Recall Tool (https://www.similacrecall.com/us/en/home.html) and type in the code on the bottom of the package, or call +1-800-986-8540 (U.S.) and follow the instructions provided. No action is needed for previously consumed product. If you have questions about feeding your child, contact your healthcare professional.

If a baby formula product you purchased is part of this recall, return to the store where you purchased the formula and ask for a refund or exchange.

Some product was distributed to countries outside the U.S. A list of these products can be found at the Abbot Product Recall Tool.

Specific instructions for Wyandotte County residents

In addition to the overall recall information, the Unified Government Public Health Department also issued guidance specifically for parents and caregivers in Wyandotte County:

• Any Wyandotte County residents who have recently received goods from the Healthy Families Wyandotte program, which included small packets of formula, should immediately check those items to make sure they are not among the recalled products.

• The Kansas Women, Infants and Children (WIC) program has approved a list of products that can replace recalled product. WIC participants can purchase these products using their WIC card to replace any recalled products.

Expiration date locations and lot numbers are printed on the Similac product package.
The Kansas Women, Infant and Children’s (WIC) program has sent out a graphic showing which formulas are approved temporarily as substitutes for the recalled formulas for WIC participants. These substitute formulas can be purchased using the WIC participant card.
  • Story from Janell Friesen, Health Department public information officer

Senate panel approves KU Med stem cell therapy grant, increased oversight for laboratories

by Noah Taborda, Kansas Reflector

Topeka — A Kansas Senate committee greenlit a bill Friday investing half a million dollars in the University of Kansas Medical Center’s plan to conduct COVID-19 stem cell therapy trials.

The $500,000 appropriation for the Midwest Stem Cell Therapy Center must be used in 2022 or 2023 to conduct a phase one clinical trial with severe COVID-19 patients. The Legislature established the center in 2013 to focus on a stem cell research program for transplant patients.

In a hearing Wednesday, representatives from the center told legislators medical professionals could use these treatments to treat patients with COVID-19 who experience extreme inflammation.

“We have an opportunity here to be on the cutting edge and leading not only the state or nation, but the world in this type of research that could lead to groundbreaking ways of using the therapies,” said Sen. Renee Erickson, R-Wichita. “They’re working to treat a variety, not just COVID-19 – which is very important – of diseases and ailments that have plagued people for decades.”

The Senate Public Health and Welfare Committee approved the bill along with a handful of other measures, including a bill to require public reporting of certain lab accidents. The initiatives now go to the Senate, where the full chamber will weigh in on the issues.

Sen. Pat Pettey, a Kansas City, Kansas, Democrat, voiced concerns about the lack of prior approval from the Food and Drug Administration for the use of these treatments for COVID-19.

“Secondly, I have concerns, and this is specific to COVID-19, with those cases decreasing whether they would have enough patients to enroll,” Pettey said. “The Midwest stem cell therapy center does good work, but I don’t see it in the purview of this committee to be making appropriations for a specific item that does not even have a trial study in place.”

A KU Medical Center representative acknowledged the potential for insufficient patients and the need to gain FDA approval as soon as possible during testimony.

A bill amending when an occupational therapist can treat a patient and what insurance they must carry, as well as a bill amending the Children’s Health Insurance Program, also gained committee approval.

A bill enacting the Biological Laboratory Accident Transparency Act raised concerns about the potential for overly burdensome regulations.

“It seems to be directed specifically toward the lab at Kansas State, which there is tremendous oversight over that lab already,” Pettey said. “It took us 10 years to get it and I feel that this is total overreach and not really being directed for the needs of our state.”

The act would require labs that deal with human pathogens or infectious diseases to report any accidents or close calls to the public. Supporters pointed to unsupported theories that COVID-19 originated from a lab in China.

Sen. Richard Hilderbrand, a Galena Republican and chairman of the Senate committee, said the oversight they had did not guarantee public knowledge.

“The transparency part, for the general public to have knowledge when there is a mishap and accident, a spillage or leakage or something like that, is imperative,” Hilderbrand said. “It’s imperative that the general population understands what’s going on, whether the origins are from a bat or from the Wuhan laboratory.”

Kansas Reflector stories, www.kansasreflector.com, may be republished online or in print under Creative Commons license CC BY-NC-ND 4.0.
See more at https://kansasreflector.com/2022/02/18/senate-panel-approves-ku-med-stem-cell-therapy-grant-increased-oversight-for-laboratories/
.